We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ETXPF market cap is 75.9M. The company's latest EPS is GBP -0.0142 and P/E is -6.34.
| Year End January 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 44k | 456k | 317k | 477k | 475k |
| Operating Income | -5.12M | -2.89M | -4.49M | -9.57M | -10.24M |
| Net Income | -4M | -2.35M | -3.68M | -8.07M | -8.27M |
| Year End January 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 7.51M | 4.79M | 14.31M | 29.76M | 34.64M |
| Total Liabilities | 707k | 284k | 427k | 1.79M | 1.6M |
| Total Equity | 6.8M | 4.5M | 13.88M | 27.97M | 33.04M |
| Year End January 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -3.7M | -2.03M | -3.36M | -7.8M | -8.01M |
| Investing | 2.5M | -1,000 | -5.07M | -9.94M | 15.31M |
| Financing | 11k | -35k | 12.6M | 22.33M | 13.05M |
| Market Cap | 75.9M |
| Price to Earnings Ratio | -6.34 |
| Price to Sales Ratio | 112.5 |
| Price to Cash Ratio | 1.66 |
| Price to Book Ratio | 1.59 |
| Dividend Yield | - |
| Shares Outstanding | 583.84M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 10k |
| 52 Week Change | -31.58% |
| 52 Week High | 0.29 |
| 52 Week Low | 0.13 |
| Spread (Intraday) | 2k (100%) |
| Company Name | E Therapeutics PLC (PK) |
| Address |
4 kingdom street london |
| Website | https://www.etherapeutics.co.uk |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
